Lakewood-Amedex: LAKEWOOD-AMEDEX APPOINTS TWO NEW BOARD MEMBERS

(marketscreener.com) SARASOTA, Fla., Jan. 25, 2022 /PRNewswire/ -- Lakewood-Amedex Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called Bisphosphocins®, today announced that two new directors have been appointed to its...https://www.marketscreener.com/news/latest/LAKEWOOD-AMEDEX-APPOINTS-TWO-NEW-BOARD-MEMBERS--37633894/?utm_medium=RSS&utm_content=20220125